Doctors Note Logo

Published on: 8/18/2026

The Science of Genetic Variants: Exploring Pathogenic Mutations in X-Linked Rickets

X-linked rickets, also called X-linked hypophosphatemia (XLH), is caused by loss-of-function pathogenic variants in the PHEX gene on the X chromosome, which lead to excess FGF23, renal phosphate wasting, and softened, poorly mineralized bone. More than 700 PHEX variants have been reported, including nonsense, frameshift, splice-site, missense, and large deletions, and because inheritance is X-linked dominant, affected fathers pass it to all daughters while mothers pass it to about half of their children. Variant type does not reliably predict severity, and roughly one in five cases arises from a new (de novo) mutation with no family history, so bowed legs, short stature, dental abscesses, and bone pain can appear unexpectedly in childhood or persist into adulthood. There are several important genetic and diagnostic factors to consider, including how XLH is distinguished from nutritional or autosomal forms of rickets, so review the complete details below before drawing conclusions. If you or your child has unexplained bone pain, leg bowing, slowed growth, or repeated dental problems, a free, instant, online symptom check can help you organize your symptoms, understand which conditions may fit, and decide what type of specialist to see next.

Last reviewed for medical accuracy: 08/18/2026

answer background

Explanation

The Science of Genetic Variants: Exploring Pathogenic Mutations in X-Linked Rickets

X-Linked Hypophosphatemia (XLH), commonly called X-linked rickets, is a rare inherited disorder that affects how the body processes phosphate. Phosphate is essential for strong bones and teeth. In XLH, mutations in the PHEX gene lead to low phosphate levels, causing bone pain, deformities, and growth issues.

Understanding the PHEX Gene

  • Location and role
    The PHEX gene sits on the X chromosome. It encodes an enzyme that helps regulate a hormone called fibroblast growth factor 23 (FGF23). When PHEX works properly, FGF23 levels stay in balance, phosphate is reabsorbed in the kidneys, and bones mineralize normally.

  • How mutations disrupt function
    Pathogenic PHEX variants often lead to too much FGF23. Excess FGF23 tells the kidneys to dump phosphate, leaving too little in the blood. Over time, this phosphate shortage weakens bones, causing the hallmark rickets symptoms.

Types of PHEX Gene Variants

Genetic changes in PHEX can take several forms:

  • Missense mutations
    A single DNA “letter” is swapped, changing one amino acid in the enzyme. This can alter its shape or stability.

  • Nonsense mutations
    A change creates an early “stop” signal, truncating the enzyme and rendering it nonfunctional.

  • Frameshift mutations
    Insertions or deletions of DNA letters shift the reading frame, scrambling the enzyme’s code.

  • Splice-site mutations
    These affect the way cells cut and paste the gene’s instructions (mRNA), often leading to missing or extra pieces.

Each variant type has different likelihoods of causing disease. For example, nonsense and frameshift mutations usually produce more severe effects than some missense changes.

The PHEX Gene Mutation Database

Researchers and clinicians rely on curated resources to track known PHEX variants:

  • What it is
    A specialized database that lists PHEX mutations reported in patients, along with key details like:

    • Variant type (missense, nonsense, etc.)
    • Predicted impact on protein function
    • Reported clinical features
    • Population frequency
  • Why it matters

    • Clinicians use it to help interpret genetic test results.
    • Researchers identify trends between specific variants and disease severity.
    • Families and support groups can learn about previously observed mutations.
  • How to use it

    1. Search by variant notation (e.g., c.871C>T or p.Arg291Ter).
    2. Review linked studies or case reports.
    3. Check classification status (pathogenic, likely pathogenic, uncertain significance, etc.).

Access to a reliable PHEX gene mutation database streamlines diagnosis and helps guide treatment decisions.

Variant Classification: Separating Benign from Pathogenic

Not every genetic change causes disease. Classifying variants follows guidelines such as those from the American College of Medical Genetics and Genomics (ACMG):

  1. Population data

    • Is this variant common in healthy individuals?
    • Rare variants (<0.01% frequency) are more suspect.
  2. Computational predictions

    • Software tools predict whether a change disrupts protein structure or splicing.
  3. Functional studies

    • Lab experiments assess enzyme activity or hormone levels.
  4. Segregation analysis

    • Tracking whether the variant co-occurs with disease in a family.
  5. Published evidence

    • Peer-reviewed reports of the same variant causing XLH.

Based on combined evidence, each variant receives one of these classifications:

  • Pathogenic
  • Likely pathogenic
  • Uncertain significance (VUS)
  • Likely benign
  • Benign

Accurate classification informs prognosis, family planning, and eligibility for emerging therapies.

Clinical Implications of PHEX Variants

  • Genotype–phenotype correlations
    While all PHEX mutations disrupt phosphate handling, some variants are linked to more severe bone deformities or early-onset dental abscesses.

  • Treatment planning

    • Conventional therapy: oral phosphate supplements and active vitamin D analogs.
    • Newer approaches: monoclonal antibodies targeting FGF23 (e.g., burosumab) show promise, particularly in patients with confirmed pathogenic PHEX variants.
  • Monitoring
    Regular blood tests track phosphate levels, kidney function, and growth in children. Imaging studies assess bone health over time.

Genetic Testing and Counseling

If XLH is suspected based on symptoms (bowed legs, delayed growth, bone pain), genetic testing for PHEX variants can:

  • Confirm the diagnosis
  • Distinguish XLH from other forms of rickets
  • Identify carriers in the family (especially mothers, given X-linkage)

Genetic counseling helps families understand inheritance patterns, recurrence risks, and implications for future pregnancies.

Staying on Top of Symptoms

Early detection and management improve quality of life. If you or a family member notice possible signs of XLH—such as persistent bone pain, growth delays, or dental issues—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

This tool can guide you on when to seek medical advice and what questions to ask your healthcare provider.

Summary and Next Steps

  • PHEX gene mutations disrupt phosphate balance, leading to X-linked rickets.
  • A dedicated PHEX gene mutation database offers valuable variant and clinical data.
  • Rigorous variant classification (ACMG guidelines) distinguishes harmful mutations from benign changes.
  • Understanding your specific PHEX variant can refine treatment choices and prognosis.
  • Genetic testing and counseling support families in managing XLH.
  • Keep track of symptoms and consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

If you suspect a serious issue or experience severe symptoms, speak to a doctor promptly. Your health is important—never delay professional medical care for anything life threatening or serious.

(References)

  • * Michigami T. [X-linked hypophosphatemic rickets]. Nihon Naika Gakkai Zasshi. 2007 Apr 10;96(4):725-30. doi: 10.2169/naika.96.725. PMID: 17506311.

  • * Toyosawa S, Oya K, Sato S, Ishida K. [Osteocyte and DMP1]. Clin Calcium. 2012 May;22(5):713-20. PMID: 22549196.

  • * Baroncelli GI, Toschi B, Bertelloni S. Hypophosphatemic rickets. Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197.

  • * Ma HW. [Rickets-like genetic diseases]. Zhongguo Dang Dai Er Ke Za Zhi. 2013 Nov;15(11):923-7. PMID: 24229581.

  • * Fuente R, Gil-Peña H, Claramunt-Taberner D, Hernández O, Fernández-Iglesias A, Alonso-Durán L, Rodríguez-Rubio E, Santos F. X-linked hypophosphatemia and growth. Rev Endocr Metab Disord. 2017 Mar;18(1):107-115. doi: 10.1007/s11154-017-9408-1. PMID: 28130634.

  • * Insogna KL, Briot K, Imel EA, Kamenický P, Ruppe MD, Portale AA, Weber T, Pitukcheewanont P, Cheong HI, Jan de Beur S, Imanishi Y, Ito N, Lachmann RH, Tanaka H, Perwad F, Zhang L, Chen CY, Theodore-Oklota C, Mealiffe M, San Martin J, Carpenter TO, AXLES 1 Investigators. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis. J Bone Miner Res. 2018 Aug;33(8):1383-1393. doi: 10.1002/jbmr.3475. Epub 2018 Jun 26. PMID: 29947083.

  • * Imel EA, White KE. Pharmacological management of X-linked hypophosphataemia. Br J Clin Pharmacol. 2019 Jun;85(6):1188-1198. doi: 10.1111/bcp.13763. Epub 2018 Oct 29. PMID: 30207609; PMCID: PMC6533442.

  • * Haffner D, Emma F, Eastwood DM, Biosse Duplan M, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. PMID: 31068690; PMCID: PMC7136170.

  • * Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16. PMID: 31104833; PMCID: PMC7179969.

  • * Miller WL, Imel EA. Rickets, Vitamin D, and Ca/P Metabolism. Horm Res Paediatr. 2022;95(6):579-592. doi: 10.1159/000527011. Epub 2022 Nov 29. PMID: 36446330.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.